PRICES include / exclude VAT
>UNE standards>UNE EN ISO 10993-9:2022 - Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019)
in stockReleased: 2022-05-25
UNE EN ISO 10993-9:2022 - Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019)

UNE EN ISO 10993-9:2022

Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019)

Evaluación biológica de productos sanitarios. Parte 9: Marco para la identificación y cuantificación de productos potenciales de degradación. (ISO 10993-9:2021).

Format
Availability
Price and currency
English PDF
Immediate download
Printable
91.08 EUR
English Hardcopy
In stock
91.08 EUR
Spanish PDF
Immediate download
Printable
75.90 EUR
Spanish Hardcopy
In stock
75.90 EUR
Standard number:UNE EN ISO 10993-9:2022
Pages:22
Released:2022-05-25
Status:Standard
Pages (Spanish):21
DESCRIPTION

UNE EN ISO 10993-9:2022

This document provides general principles for the systematic evaluation of the potential and observed degradation of medical devices through the design and performance of in vitro degradation studies. Information obtained from these studies can be used in the biological evaluation described in the ISO 10993- series. This document considers both materials designed to degrade in the body as well as materials that are not intended to degrade. This document is not applicable to: a) evaluation of degradation which occurs by purely mechanical processes; methodologies for the production of this type of degradation product are described in specific product standards, where available; NOTE Purely mechanical degradation causes mostly particulate matter. Although this is excluded from the scope of this document, such degradation products can evoke a biological response and thus need to undergo biological evaluation as described in other parts of ISO 10993. b) leachable components which are not degradation products; c) medical devices or components that do not contact the patient's body directly or indirectly.